Pleural abnormalities in COVID-19: a narrative review

• Published in: Journal of thoracic disease Vol. 13; no. 7; pp. 4484 - 4499
• Main Authors: Saha, Biplab K, Chong, Woon H, Austin, Adam, Kathuria, Ritu, Datar, Praveen, Shkolnik, Boris, Beegle, Scott, Chopra, Amit
• Format: Journal Article
• Language: English
• Published: China AME Publishing Company 01.07.2021
• Subjects: Review; COVID-19; pleura; pleural effusion; radiology; pneumothorax
• ISSN: 2072-1439; 2077-6624
• DOI: 10.21037/jtd-21-542

This narrative review aims to provide a detailed overview of pleural abnormalities in patients with coronavirus disease 19 or COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is a novel beta coronavirus responsible for COVID-19. Although pulmonary parenchymal and vascular changes associated with COVID-19 are well established, pleural space abnormalities have not been the primary focus of investigations. Narrative overview of the medical literature regarding pleural space abnormalities in COVID-19. The appropriate manuscripts were identified by searching electronic medical databases and by hand searching the bibliography of the identified papers. Pleural abnormalities on transverse and ultrasound imaging are discussed. The incidence, clinical features, pathophysiology, and fluid characteristics of pleural effusion are reviewed. Studies reporting pneumothorax and pneumomediastinum are examined to evaluate for pathogenesis and prognosis. A brief comparative analysis of pleural abnormalities among patients with COVID-19, severe acute respiratory syndrome (SARS), and Middle Eastern respiratory syndrome (MERS) has been provided. Radiologic pleural abnormalities are common in COVID-19, but the incidence of pleural effusion appears to be low. Pneumothorax is rare and does not independently predispose the patient to worse outcomes. SARS-CoV-2 infects the pleural space; however, whether the pleural fluid can propagate the infection is unclear.